Fungal infections, named mycosis, can cause severe invasive and systemic diseases that
can even lead to death. In recent years, epidemiological data have recorded an increase in …

Candida auris is a major emerging human fungal pathogen that was first reported in 2009 as
an isolate from the ear canal of a patient in Japan [1]. Since this initial report, C. auris has …

Candida auris is an emerging fungus that represents a serious health threat globally. In Italy,
the first case was detected in July 2019. Then, one case was reported to the Ministry of …

Virtually all Candida species linked to clinical candidiasis are capable of forming highly
resistant biofilms on different types of surfaces, which poses an additional significant threat …

Fungal infections cause severe and life-threatening complications especially in
immunocompromised individuals. Antifungals targeting cellular machinery and cell …

There is a global health concern associated with the emergence of the multidrug-resistant
(MDR) fungus Candida auris, which has significant mortality rates. Finding innovative and …

In vitro interactions between tacrolimus, a calcineurin inhibitor, and fluconazole,
itraconazole, caspofungin, or anidulafungin were evaluated against Candida auris, C …

Candida auris has drawn global attention due to its alarming multidrug resistance and the
emergence of pan resistant strains. C. auris poses a significant risk in nosocomial …

Novel antifungal drugs are urgently needed to treat candidiasis caused by the emerging
fungal multidrug-resistant pathogen Candida auris. In this study, the most cost-effective drug …

Candida auris, a rapidly emerging multidrug-resistant fungal pathogen, poses a global
health threat, with cases reported in over 47 countries. Conventional detection methods …